Active Ingredient(s): Bempedoic Acid
FDA Approved: * February 21, 2020
Category: Cholesterol

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Nexletol Overview

Bempedoic acid, sold under the brand name Nexletol among others, is a medication for the treatment of hypercholesterolemia (high blood cholesterol levels).[2][3] The most common side effects include hyperuricemia (high blood levels of uric acid), pain in arms or legs, and anemia (low red blood cell counts).[3] Bempedoic acid blocks an enzyme in the liver called adenosine triphosphate-citrate lyase, which is involved in making cholesterol. ...

Read more Nexletol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Nexletol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Bempedoic Acid
  • Tablet: 180mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Nexletol: (1 result)

Sorted by National Drug Code
  • 72426-118 Nexletol 180 mg Oral Tablet, Film Coated by Esperion Therapeutics, Inc.

Other drugs which contain Bempedoic Acid or a similar ingredient: (3 results)